Načítá se...
The past, present, and future of CRM1/XPO1 inhibitors
Therapies targeted at inhibiting nucleo-cytoplasmic transport have found broad applications in the field of oncology. Chromosome region maintenance 1 (CRM1), better known as exportin 1 (XPO1), is the protein transporter responsible for the nucleo-cytoplasmic shuttling of most of the tumor suppressor...
Uloženo v:
| Vydáno v: | Stem Cell Investig |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6414360/ https://ncbi.nlm.nih.gov/pubmed/30976603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2019.02.03 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|